Growth Metrics

Avanos Medical (AVNS) Cash from Investing Activities (2016 - 2024)

Historic Cash from Investing Activities for Avanos Medical (AVNS) over the last 12 years, with Q4 2024 value amounting to -$7.6 million.

  • Avanos Medical's Cash from Investing Activities fell 10938.27% to -$7.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$27.5 million, marking a year-over-year decrease of 22731.48%. This contributed to the annual value of -$27.5 million for FY2024, which is 22731.48% down from last year.
  • Per Avanos Medical's latest filing, its Cash from Investing Activities stood at -$7.6 million for Q4 2024, which was down 10938.27% from -$12.0 million recorded in Q3 2024.
  • Avanos Medical's 5-year Cash from Investing Activities high stood at $81.0 million for Q4 2023, and its period low was -$121.7 million during Q1 2022.
  • For the 5-year period, Avanos Medical's Cash from Investing Activities averaged around -$9.3 million, with its median value being -$5.4 million (2020).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 203508.77% in 2022, then soared by 175306.12% in 2023.
  • Quarter analysis of 5 years shows Avanos Medical's Cash from Investing Activities stood at -$5.1 million in 2020, then rose by 7.84% to -$4.7 million in 2021, then decreased by 4.26% to -$4.9 million in 2022, then surged by 1753.06% to $81.0 million in 2023, then plummeted by 109.38% to -$7.6 million in 2024.
  • Its Cash from Investing Activities stands at -$7.6 million for Q4 2024, versus -$12.0 million for Q3 2024 and -$5.9 million for Q2 2024.